Clear. 36.1   F New York
AI-Powered News Summarizer
Asia

Almost a million people have been given an experimental Chinese coronavirus vaccine

November 20, 2020. Summarized by summa-bot.

BEIJING, April 14, 2020.A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. China has approved two COVID-19 inactivated vaccine candidates for clinical trials, according to the State Council joint prevention and control mechanism against the coronavirus Tuesday. The two vaccine candidates are developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group ,Sinopharm, and Sinovac Research and Development Co., Ltd, a company based in Beijing. Clinical trials of the two vaccines have started. (Photo by Zhang Yuwei/Xinhua via Getty)

Almost a million people have been given an experimental coronavirus vaccine developed by Sinopharm as part of an emergency-use program authorized by Beijing, the Chinese pharmaceutical giant's chairman said.

Hong Kong (CNN)Almost a million people have been given an experimental coronavirus vaccine developed by Sinopharm as part of an emergency-use program authorized by Beijing, the Chinese pharmaceutical giant's chairman said.

No serious adverse effects have been reported from vaccine recipients so far, Sinopharm said Wednesday in an article on social media platform WeChat, citing Chairman Liu Jingzhen.

Liu said the vaccine had been given to Chinese construction workers, diplomats, and students who have gone to more than 150 countries around the world during the pandemic -- and none of them has reported an infection.

He said on November 6 that there were 56,000 people who had received emergency vaccinations and then gone overseas.

And later, an outbreak broke out in the office, 10 of the 18 people who were not vaccinated were infected and none of those vaccinated were infected," he said.

In June, Chinese company CanSino Biologics announced it had been given special authorization to administer its experimental vaccine to the People's Liberation Army.

Since July, Chinese drug makers have been administering experimental vaccines to people working in "high-risk" professions under the emergency use program, which allows vaccine candidates to be used on a limited scale before their safety and efficacy have been fully proven by clinical trials.

It comes after Pfizer announced the results of its Phase 3 coronavirus vaccine trials on Wednesday, which it said was 95% effective in preventing infections -- even in older adults -- and caused no serious safety concerns.

Dr. Anthony Fauci, the top US infectious disease expert, said the Pfizer and Moderna vaccines had shown extraordinary efficacy.

Summarizer is on Google News. Now you can get the latest AI summarized news on your favorite news platform.

Don't like Google News? We have an RSS Feed for you.

Suggestions